Cleared Special

K100958 - MODIFICATION TO: MICROBLADE SHAVER AND ACCESSORIES (FDA 510(k) Clearance)

Class II Neurology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K100958 · Baxano, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2010
Decision
107d
Days
Class 2
Risk

K100958 is an FDA 510(k) clearance for the MODIFICATION TO: MICROBLADE SHAVER AND ACCESSORIES. Classified as Rongeur, Manual (product code HAE), Class II - Special Controls.

Submitted by Baxano, Inc. (San Jose, US). The FDA issued a Cleared decision on July 23, 2010 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4840 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Baxano, Inc. devices

Submission Details

510(k) Number K100958 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 07, 2010
Decision Date July 23, 2010
Days to Decision 107 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 148d · This submission: 107d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code HAE Rongeur, Manual
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4840
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAE Rongeur, Manual

All 35
Devices cleared under the same product code (HAE) and FDA review panel - the closest regulatory comparables to K100958.
Geister K-Rex rongeurs
K242759 · Geister Medizin Technik GmbH · Jun 2025
SQ.line KERRISON
K223596 · Aesculap, Inc. · Jun 2023
Rebellion, Phantom Multi-Bite Kerrison Rongeur
K230256 · Morpheus AG · Mar 2023
Rebellion
K221818 · Morpheus AG · Oct 2022
KLS Martin Neuro Rongeurs
K210741 · KLS-Martin L.P. · Jun 2022
Rebellion, Phantom Multi-Bite Kerrison Rongeur 
K200768 · Morpheus AG · May 2021